PIGU
GPI-anchor transamidase component PIGU
Also known as: bA346K17.2, CDC91L1, GAB1, PIGU_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H490
- Gene
- PIGU
- Ensembl
- ENSG00000101464
- Chromosome
- 20
- Canonical length
- 435 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
The protein encoded by this gene shares similarity with Saccharomyces cerevisiae Cdc91, a predicted integral membrane protein that may function in cell division control. The protein encoded by this gene is the fifth subunit of GPI transamidase that attaches GPI-anchors to proteins. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
435 residues, UniProt reviewed canonical sequence.
>Q9H490|PIGU
1 MAAPLVLVLV VAVTVRAALF RSSLAEFISE RVEVVSPLSS WKRVVEGLSL LDLGVSPYSG
61 AVFHETPLII YLFHFLIDYA ELVFMITDAL TAIALYFAIQ DFNKVVFKKQ KLLLELDQYA
121 PDVAELIRTP MEMRYIPLKV ALFYLLNPYT ILSCVAKSTC AINNTLIAFF ILTTIKGSAF
181 LSAIFLALAT YQSLYPLTLF VPGLLYLLQR QYIPVKMKSK AFWIFSWEYA MMYVGSLVVI
241 ICLSFFLLSS WDFIPAVYGF ILSVPDLTPN IGLFWYFFAE MFEHFSLFFV CVFQINVFFY
301 TIPLAIKLKE HPIFFMFIQI AVIAIFKSYP TVGDVALYMA FFPVWNHLYR FLRNIFVLTC
361 IIIVCSLLFP VLWHLWIYAG SANSNFFYAI TLTFNVGQIL LISDYFYAFL RREYYLTHGL
421 YLTAKDGTEA MLVLKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PIGU can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 8
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 27 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 27 nTPM
- spinal cord: 27 nTPM
- fallopian tube: 24 nTPM
- choroid plexus: 22 nTPM
- rectum: 21 nTPM
- ovary: 20 nTPM
Single-cell type
- oligodendrocytes: 120 nCPM
- myonuclei: 102 nCPM
- cone photoreceptor cells: 97 nCPM
- respiratory ciliated cells: 91 nCPM
- rod photoreceptor cells: 76 nCPM
- renal collecting duct intercalated cells: 71 nCPM
Immune cell
- memory CD8 T-cell: 18 nTPM
- NK-cell: 17 nTPM
- gdT-cell: 16 nTPM
- naive CD8 T-cell: 15 nTPM
- memory CD4 T-cell: 15 nTPM
- naive CD4 T-cell: 15 nTPM
Brain region
- white matter: 40 nTPM
- basal ganglia: 27 nTPM
- medulla oblongata: 27 nTPM
- pons: 26 nTPM
- cerebellum: 24 nTPM
- cerebral cortex: 24 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PIGU.
Disease | AllUniProt
Conditions PIGU is implicated in, by any mechanism.
- Neurodevelopmental disorder with brain anomalies, seizures, and scoliosis (NEDBSS) MIM:618590
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 141 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Glycosylphosphatidylinositol biosynthesis defect 21
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.87
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.72
- DepMap mean gene effect
- -0.2
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 15% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- attachment of GPI anchor to protein
- GPI anchor biosynthetic process
- GPI anchored protein biosynthesis
- regulation of receptor signaling pathway via JAK-STAT
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- GPI transamidase subunit PIG-U
- GPI transamidase subunit PIG-U
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PIGU as an antibody target. Whether an autoantibody or antibody against PIGU could matter depends on whether native PIGU is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PIGU is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PIGU as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...